AKT1 and neoplasm: Pretreatment of these tumor cell lines with a specific PI3K inhibitor reverses the massive apoptotic effect, suggesting the future exploration of immunotherapy in combination with drugs targeting the PI3K/AKT/mTOR pathway [39].